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Carbohydrate bindingThe lectins, a class of proteins that occur widely in animals, plants, fungi, lichens andmicroorganisms, are known
for their ability to speciﬁcally bind to carbohydrates. Plant lectins can be classiﬁed into 12 families including the
Galanthus nivalis agglutinin (GNA)-related lectin superfamily, which is widespread among monocotyledonous
plants and binds speciﬁcally to mannose, a behavior that confers remarkable anti-tumor, anti-viral and insecti-
cidal properties on these proteins. The present study characterized a mitogenic lectin from this family, called
tarin, which was puriﬁed from the crude extract from taro (Colocasia esculenta). The results showed that tarin
is a glycoprotein with 2–3% carbohydrate content, composed of least 10 isoforms with pIs ranging from 5.5 to
9.5. The intact protein is a heterotetramer of 47 kDa composed of two non-identical and non-covalently associ-
ated polypeptides, with small subunits of 11.9 kDa and large subunits of 12.6 kDa. The tarin structure is stable
and recovers or maintains its functional structure following treatments at different temperatures and pH. Tarin
showed a complex carbohydrate speciﬁcity, binding with high afﬁnity to high-mannose and complex N-
glycans. Many of these ligands can be found in viruses, tumor cells and insects, as well as in hematopoietic pro-
genitor cells. Chemical modiﬁcations conﬁrmed that both conserved and non-conserved amino acids participate
in this interaction. This study determined the structural and ligand binding characteristics of a GNA-related lectin
that can be exploited for several different purposes, particularly as a proliferative therapeutic molecule that is
able to enhance the immunological response.
© 2014 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Plant lectins comprise a group of proteins with at least one non-
catalytic domain and the ability to bind speciﬁcally and reversibly to
simple or complex carbohydrates [1,2] through hydrogen bonds or
Van der Waals interactions. Lectins may or may not show agglutinating
activity or glycoconjugate precipitation [3].
Molecular and high-resolution techniques such as Nuclear Magnetic
Resonance (NMR) and X-ray crystallography have been widely used to
characterize plant lectins [4,5], revealing a heterogeneous group of
proteins that vary widely in size, structure, molecular organization, and
the constitution of their binding sites [6]. These proteins share many of+55 21 3938 7266.
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. This is an open access article underthe characteristics that deﬁne different groups of evolutionary and struc-
turally related proteins, and consist of 12 families of plant lectins including
themonocotmannose-binding lectin family, recently called theGalanthus
nivalis agglutinin (GNA)-related lectin superfamily, which includes tarin
[7]. The GNA-related family has attracted special attention because of
the insecticidal, antiviral and antitumor activities of its members [8].
The lectins from the GNA-related lectin superfamily show consider-
able differences in their processing and post-translational modiﬁca-
tions. In general, these proteins are synthesized as preproproteins in
the endoplasmic reticulum, and after processing (removal of the signal
peptide and proteolytic cleavage of the C-terminal peptide), can origi-
nate two types of protomers of one or two domains. The two-domain
protomers (about 30 kDa) originate two monomers, with identical or
similar masses, by proteolytic cleavage. The one-domain protomers
(11–14 kDa) originate a single monomer. The resulting monomers
(with masses ranging from 11 to 14 kDa) can combine to form a
homo/hetero-dimer or tetramer [5,9].
Members of the GNA-related lectin family exhibit a unique β-prism
fold and bind exclusively to mannose. Each monomer folds into a β-the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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by four antiparallel β-strands interconnected byΩ loops. Their speciﬁc-
ity is determined by the presence of three binding sites, located in each
of the three subdomains (I, II and III), which contain a conserved motif
QXDXNXVXY that may or may not be functional [10,11].
In this study, a simple and reproducible strategy based on Cibacron
blue chromatography, previously described, was used to purify a
12 kDa protein identiﬁed as the lectin from taro [Colocasia esculenta
(L.) Schott], called tarin [12]. Taro is a monocotyledonous plant of the
family Araceae, native to Asia; its large starchy underground corm is
widely consumed in many countries [13]. Tarin is encoded by the tar1
gene and has a two-domain protomer of 28 kDa,which is proteolytically
processed into two different monomers of about 12.5 kDa. The protein
binds speciﬁcally tomannose, i.e., is amember of the GNA-related lectin
superfamily [14–16].
Themolecularmass of tarin is an open issue, since it has been report-
ed to be 25 or 50 kDa [14–17]. The present study analyzed the structural
characteristics of tarin, including its native mass, quaternary structure
stability, the presence of isoforms in this preparation, and the presence
of glycosylation. The binding speciﬁcity was also studied, using glycan
microarray techniques together with modiﬁcation of amino acids, to
determine the participation of certain amino acids in mannose binding.
2. Materials and methods
2.1. Puriﬁcation of tarin
Tubers of taro were purchased from a local market in Rio de Janeiro,
Brazil. Crude extractswere prepared as described by Roy and colleagues
[18]. One hundred grams of taro was homogenized in 0.2 M NaCl con-
taining 1 g/L ascorbic acid (10 mL/g fresh weight) at pH 7.0 in aWaring
blender. The homogenate was ﬁltered through 4 layers of cheesecloth
and centrifuged at 3000 ×g for 10 min. CaCl2 (20 mM) was added to
the supernatant, the pH adjusted to 9.0, and the suspensionwas allowed
to standovernight at 8 °C. Next, itwas centrifuged at 3000×g for 10min
and the supernatant was pooled, adjusted to pH 4.0 and centrifuged at
3000 ×g for 10 min. The clear solution was adjusted to pH 7.5, allowed
to stand overnight in an ice bath, and the precipitate formed was re-
moved by centrifugation at 9000 ×g for 20 min. The crude extract was
applied to a Cibacron Blue 3GA column (4% beaded agarose matrix)
(1.6 × 20 cm) previously equilibrated with 10 mM Tris–HCl pH 7.5.
The column was washed with the same buffer, and the bound protein
was elutedwithwash buffer containing 0.4MNaCl. Flow ratewasmain-
tained at 1.7 mL/min, and 2 mL fractions were collected during the
elution step until the absorbance at 280 nm dropped below 0.01/mL.
The protein concentration was estimated by the method of Lowry [19],
using bovine serum albumin (BSA) as a standard.
2.2. Agglutination and sugar inhibition evaluation
Hemagglutination assays were carried out using formaldehyde-
treated rabbit erythrocytes (obtained from the Unit for Laboratory
Animal Medicine at the University of Michigan) in a 96-well microti-
ter plate. Puriﬁed tarin solutions (30 μL) were serially diluted with
phosphate-buffered saline (PBS) pH 7.2, followed by the addition
of 30 μL of the 2% (v/v) rabbit erythrocyte suspension. The results
were observed after 1 h and recorded as hemagglutination units
(HU), which correspond to the smallest amount of protein that
causes hemagglutination. For inhibition assays, a tarin solution (at
least 4 HU, previously determined) was incubated for 10–15 min
with a ﬁxed concentration of various ligands, followed by the addition
of 30 μL of 2% erythrocyte solution. Those ligands that were able to in-
hibit hemagglutination were serially diluted and the agglutination as-
says repeated to determine the minimum inhibitory concentration
(MIC).2.3. Determination of molecular mass of intact tarin by ESI-MS and
MALDI-MS mass spectrometry
ESI-MS analysis was performed at the Protein Structure Facility at
theUniversity ofMichigan, using a nanoAcuity/Qtof Premier instrument
in positive ion mode. For denaturing conditions, tarin at 1.35 mg/mL
was diluted (1:10) in 0.1% formic acid and 9 μL was injected into a pro-
tein microdesalting column. The LC gradient was 5% buffer B (0.1%
formic acid in acetonitrile) to 90% B over 10 min. Flow rate was 30 μL
per min. The mass accuracy is ±0.01%. Under non-denaturing condi-
tions, the sample was analyzed by direct infusion of the 1.35 mg/mL
sample, without dilution or modiﬁcation of the buffer.
MALDI-TOF-MS analysis was performed on an Applied Biosystems
4700 Proteomics Analyzer 66 (TOF/TOF) using facilities provided by
the Universidade de Aveiro. Puriﬁed non-digested protein in 10 mM
Tris–HCl pH 7.5 or distilled water was deposited onto a probe plate,
using α-cyano-4-hydroxycinnamic acid as the matrix.
2.4. Size exclusion chromatography with SEC-MALS
Tarin at 2.45 mg/mL was run on aWTC-030S5 SEC column attached
to anÄKTAHPLC system in-linewith aDawnHeleos IIMulti-Angle Laser
Light Scattering (MALS) instrument, anOptilab T-rEX differential refrac-
tometer, and a UV spectrometer. Chromatographic separation was
achieved under isocratic conditions using phosphate buffered saline
pH 7.4 as a mobile phase, at 10° C, and the ﬂow rate was held at
0.350 mL/min. The output signals were imported into Astra 6 software
(Wyatt Technology Corporation), using the Zimmmodel.
2.5. Heat treatment of tarin
The effect of temperature on tarin stability was evaluated according
to Pan and colleagues [20], by heating aliquots of tarin (1mg/mL) at 30,
40, 50, 60, 70, 80 or 90 °C for 30 min, cooling at 4 °C and assaying for
hemagglutinating activity. Non-treated protein was considered as
100% active.
2.6. Effect of pH on tarin stability
pH pretreatment of tarin was performed according to Pan and
colleagues [20]. Tarin solution (10 μL at 1 mg/mL) was incubated for 1
h with 90 μL of various buffer solutions. Aliquots of 50 μL of the treated
protein were then mixed with 50 μL of 0.25 M Tris–HCl pH 7.5 contain-
ing 0.3 M NaCl to adjust the pH, and an aliquot of the mixture (30 μL)
was serially diluted by adding 25 mM Tris–HCl pH 7.5 and 0.15 M
NaCl, and tested for hemagglutinating activity. The following buffers
were used: 1 N HCl (pH 1.0), 50 mM Glycine-HCl (pH 2.0–3.0),
50 mM acetate buffer (pH 4.0–5.0), 50 mM phosphate buffer (pH 6.0–
7.0), 50mMTris–HCl buffer (pH8.0–9.0) and 50mMsodiumbicarbonate
buffer (pH 10.0–11.0).
2.7. Metal ion requirement for tarin activity
An aliquot (100 μL) of the tarin in elution buffer (548 μg/mL) was
pre-incubated in the presence of 5 mM EDTA pH 7.2 for 1 h at room
temperature. The tarin solution was serially diluted in PBS pH 7.2
containing 5 mM EDTA, and the agglutination activity was evaluated.
2.8. Two-dimensional electrophoresis (2-DE) fractionation
Tarin was fractionated using the Multiphor II system (Amersham
Pharmacia Biotech, Uppsala, Sweden). Tarin (100 μg) in rehydration
buffer (8 M urea, 2% CHAPS, 2% Immobilized pH gradient (IPG) buffer
and trace of bromophenol blue) was incubated with the IPG strips (pH
range 3.0–10) at room temperature for 18 h, after which, IEF was per-
formed at 20 °C. After the ﬁrst dimension was run, the strip was treated
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0.01% bromophenol blue and 100 mg of dithiothreitol) and with
blocking buffer (1.5 M Tris–HCl, 6 M urea, 30% glycerol, 2% SDS, 0.01%
bromophenol blue and 250 mg iodoacetamide). The second dimension
was run in a polyacrylamide gel with a gradient of 12–14% with SDS
(Excel-Gel XL SDS 12–14; Amersham Biosciences) at 15 °C. Spots re-
vealed by 0.2% Coomassie blue staining were digested with trypsin
(20 ng/μL), desalted using ZIPTip C18, mixed with the matrix solution
(1:1 acetonitrile/water containing 0.3% formic acid) and deposited
onto a probe plate using α-cyano-4-hydroxycinnamic acid as the
matrix.
2.9. Carbohydrate content estimation
The neutral carbohydrate content of tarin was quantiﬁed by the
phenol-sulfuric acid method [21]. In brief, tarin aliquots were treated
with 62 μL of 80% phenol. Then, 5 mL of concentrated sulfuric acid was
added rapidly, directly onto the liquid surface in order to obtain good
mixing. The tubes were allowed to stand for 10 min, followed by shak-
ing and placed in a water bath at 25–30 °C for 10 to 20 min before the
absorbance was read at 490 nm. The content of carbohydrate-binding
to tarin was determined through comparison to a standard glucose
reference.
2.10. Chemical modiﬁcation of amino-acid residues
The effects of chemical modiﬁcation of amino-acid residues were
evaluated based on the changes in tarin hemagglutinating activity.
Tryptophan residues were modiﬁed according to the method of
Tawﬁk [22] using the Koshland reagent. Serine, tyrosine and lysine
were modiﬁed according to the protocol of Sharma and colleagues
[23] using phenylmethylsulfonyl ﬂuoride (PMSF), N-acetylimidazole
and sodium borohydride (NaBH4) reagents, respectively.
To modify sulfhydryl groups, the method of Tawﬁk [24] was follow-
ed, using 5 mM5-5′-dithio-bis (2-nitrobenzoic acid) (DTNB or Ellman's
reagent).
Cysteine was also carboxymethylated following themethod of Aitken
and Learmonth [25], using β-mercaptoethanol and iodoacetamide.
Arginine was modiﬁed according to the protocol of Tawﬁk [26], using
p-hydroxyphenylglyoxal.
Aspartic and glutamic acids were modiﬁed according to the method
of Tawﬁk [27], using 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide.
2.11. Glycan microarray
Analysis was undertaken using the Core H of the Consortium for
Functional Glycomics (http://www.functionalglycomics.org/). Tarin
was directly labeled with Alexa Fluor 488, scanned, and analyzed ac-
cording to the protocol (Direct Binding Protocol and Scanning and Anal-
ysis Protocol) provided on the web page. The complete data can be
viewed on the CFG website (search for C. esculenta at http://www.
functionalglycomics.org/glycomics/publicdata/selectedScreens.jsp?
sortBy=proteinName&sortOrder=asc).
3. Results and discussion
3.1. Tarin native molecular mass determination
Tarin was chromatographed on a Cibacron Blue 3GA column, and
was eluted with 0.4 M NaCl added to Tris–HCl 10 mM pH 7.5 [12].
The puriﬁed tarin was run on SDS-PAGE in the presence or absence
of β-mercaptoethanol and a single band was recovered, with an
estimated molecular mass of ~12 kDa (Fig. 1A). This is in agreement
with previous reports [14–16] showing that the tarin subunits are
held together by non-covalent bonds.The exact molecular mass of the subunits was determined by
mass spectrometry (MALDI-MS and ESI-MS) under denaturing
conditions (Fig. 1B). In both cases, two monomeric units with masses
of 11,928.4 Da and 12,685.1 Da (MALDI-MS) or 11,924.7 Da and
12,680.0 Da (ESI-MS) were observed, although they were not resolved
on SDS-PAGE. Tarin was also analyzed by non-denaturing ESI-MS
through the direct infusion of the puriﬁed protein without dilution or
modiﬁcation of the buffer, in order to determine the native mass of
the protein. Again, individual subunits with molecular masses of
11,924.7 Da and 12,681.6 Da were observed. There was no evidence of
a heterodimer or higher-molecular-weight structure (results not
shown), probably because the salt concentration in the original sample
was high enough to separate its monomers. The mass spectrometry
results reinforce the supposition that the subunits are held together
by non-covalent bonds.
In an attempt to determine the native molecular mass of tarin, the
puriﬁed protein was run on a gel ﬁltration Sepharose CL-6B column in
50mMTris–HCl pH 7.5with no salt, and the estimated nativemolecular
mass of tarin was 26.6 kDa (data not shown). To prevent interactions
between the protein and the resinmatrix, the gel-ﬁltration fractionation
was repeated on a Superose-12 column equilibrated with PBS buffer pH
7.4 and 0.2 Mmannose [17]. Themolecularmass of tarin was estimated
to be 30 kDa (data not shown). To reconcile the differences between the
two gel-ﬁltration procedures and to evaluate the possibility that the
protein has a delayed elution pattern due to matrix interaction [28],
tarin was loaded onto a silica-based size exclusion HPLC column with
an in-linemulti-angle light scattering detector coupledwith a refractive
index unit and UV detector. The peak was monodispersed, and the
mean molecular mass was 47 kDa, as estimated by the Zimm meth-
odology (Fig. 1C). Taken together, these data indicate that the tarin
quaternary structure corresponds to a heterotetramer, as previously
reported by Van Damme and colleagues [17], and differs from the
structures reported by [14–16].3.2. Tarin isoform analysis
In previous studies, the crude extract from taro was analyzed by
two-dimensional electrophoresis, showing that the 12 kDa polypeptide
band is composed of 5 major tarin subunit isoforms (pI ranging from
5.5 to 7.9). Four of them were identiﬁed as G1a, G1b, G1c and G1d
by N-terminal sequencing [16,29]. N-terminal sequencing clustered
the peptides in two groups, G1a/G1c and G1b/G1d, showing high
intragroup identity, but sharing only 25% intergroup sequence similari-
ty. They originated from the tarin precursor polypeptide with G1b/G1d
at the N-terminus and G1a/G1c at the C-terminus [29]. Similarly,
Monte-Neshich and colleagues [13] reported the existence of at least
10 isoforms, with pIs ranging from 5.5 to 9.5.
Since the afﬁnity puriﬁcation of tarin is not dependent on sugar
binding, it was shown here that the tarin preparation is composed of a
heterogeneous mixture of isolectins with similar molecular masses
(47 kDa). This feature is a common characteristic of lectins from
the GNA-related superfamily [30]. In contrast to previous studies that
analyzed the crude extract, the present study reports the analysis,
by 2D electrophoresis, of the puriﬁed tarin. This analysis resulted in
16 spots with apparent molecular masses of about 12 kDa and differ-
ent pIs ranging from 6.5 to 9.5 (Fig. 1D). MALDI-TOF-TOF mass
spectrometry and database searching for peptides generated by
tryptic in-gel digestion of these spots conﬁrmed, with a high degree
of reliability, that at least 10 of them were tarin subunit isoforms
(Table 1). Furthermore, MALDI-TOF spectra of three spots (labeled 1, 5
and 10 in Fig. 1D) showed masses corresponding to the N-terminal
region of the G1a (2226.1189 Da, NIPFTDNLLFSGQVLYGDGR), G1b
(2045.0631 Da, LGTNYLLSGQTLNTDGHLK) and G1d (2046.0502 Da,
LGTNYLLSGQTLDTDGHLK) isoforms, and their identities were conﬁrmed
by MS/MS (Table 1). Our ﬁndings are similar to those of Monte-Neshich
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with about 12 kDa, and differ from the ﬁndings of other groups [16,29].
Charge heterogeneity among GNA-related lectins is not unusual,
since it was reported in four araceous GNA-related tuber lectins from
Arisaema consanguineum, Arisaema curvatum, Sauromatum guttatumFig. 1. Tarin identiﬁcation and characterization. (A) The horizontal line represents a plot of them
The averagemolecularmass was calculated to be 47,130 Da. (B) 12.5% SDS-PAGE in the presenc
(C) Analysis of tarin in solution byMALDI-MS prior tryptic digestion. (D) Puriﬁed tarin (100 μg)
sion and a polyacrylamide gradient gel (12–14%) containing SDS in the second dimension. Prote
circled in red.and Gonatanthus pumilus [31]. Another araceous tuber lectin, from
Arum maculatum, also showed isoforms encoded by a family of genes
[17].
Tarin microheterogeneity can be explained, at least partially, by the
existence of allelic forms of the tar1 gene. Southern blot analysis of theolar mass of tarin vs. time. The UV signal at 280 nm is overlaid, showing a peak at 9.3min.
e (lane 2) or absence (lane 3) of β-mercaptoethanol andmolecular mass markers (lane 1).
was fractionated by 2-DE using an immobilized pH gradient (pH 3–10) in the ﬁrst dimen-
in spots were stainedwith Coomassie blue. The spots identiﬁed bymass spectrometry are
Fig. 1 (continued).
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mRNA [16] revealed three different bands. These results, together
with the occurrence of tarin subunits with nearly identical N-
terminal sequences [29], reinforce the hypothesis that tarin is encoded
by a small gene family. Alternatively, some tarin subunit isoforms could
result from the heterogeneity in the oligosaccharide chain, as suggested
by Hayes and Goldstein [32], or could be artifacts produced during the
isolation procedures, by deamidation of asparagine or glutamine side
chains [33].3.3. Carbohydrate content analysis
Neutral carbohydrate content linked to the tarin primary structure
was estimated to be approximately 2–3% of molecular mass, by the
phenol-sulfuric acid method [21]. The low glycosylation of tarin is in
agreement with the 0.47 to 1.47% carbohydrate contents of ﬁve mono-
cot mannose-binding lectins from members of the family Araceae [31,
34]. Further studies are necessary to determine the glycosylation site
and the oligosaccharide structure of tarin.
Table 1
Identiﬁcation of 2D-Gel spots by mass spectrometry (MALDI-MS).
Spota Identiﬁcation UniProt accession no. CI % Protein score Covered (%)
1 Lectin from C. esculenta A5HMM7_COLES 100 138 19.20
Globulin G1b (fragment) Q9S8T5_COLES 99.59 92 79.16
2 Lectin from C. esculenta A5HMM7_COLES 100 131 19.19
3 Lectin from C. esculenta A5HMM7_COLES 100 153 19.19
4 Lectin from C. esculenta A5HMM7_COLES 100 149 28.12
5 Lectin from C. esculenta A5HMM7_COLES 100 252 51.34
Globulin G1a (fragment) Q9S8T3_COLES 99.626 93 58.82
6 Lectin from C. esculenta A5HMM7_COLES 100 156 27.23
9 Lectin from C. esculenta A5HMM7_COLES 100 135 19.19
10 Lectin from C. esculenta A5HMM7_COLES 100 218 28.12
Globulin G1d (fragment) Q9S8T3_COLES 99.999 118 100
13 Lectin from C. esculenta A5HMM7_COLES 100 198 28.12
14 Lectin from C. esculenta A5HMM7_COLES 100 209 35.71
a Protein spot number follows the identiﬁcation in 2D-Gels shown in Fig. 1D.
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Tarin retained 100% of its hemagglutinating activity when exposed
to pHs ranging from 1 to 11 for 1 h (Fig. 2A) or to temperatures up to
70 °C for 30 min, and dropped to 37% and 25% of its initial activity
after exposure to 80 °C and 90 °C, respectively (Fig. 2B). The stability
of the tarin quaternary structure, evaluated by the ability to easily
maintain or recover itself after exposure to extreme temperature
and pH conditions, has also been reported for other monocot
mannose-binding lectins from species of Araceae [31,35]. Tarin's sta-
bility over a wide pH range confers resistance to degradation within
the insect digestive tract, increasing its potential against insects [18,
36]. Tarin does not require metal ions for its hemagglutinating activ-
ity, since treatment with 5 mM EDTA for 1 h showed no effect (data
not shown).Fig. 2. Tarin stability following pH and heat treatments. Effect of pH (A) and temperature
(B) on tarin hemagglutinating activity. Tarin was treated at different pHs for 1 h, and its
activity was determined after the pHwas readjusted to 7.5. Tarin was treated at different
temperatures for 30 min, and the hemagglutinating activity was tested after the samples
were cooled. Untreated-tarin hemagglutinating activity was considered to be 100% activ-
ity. Values are means of three independent experiments.3.5. Chemical modiﬁcation studies
Manymonocotmannose-binding lectins share a common conserved
motif, QXDXNXVXY, at the carbohydrate binding site, which confers the
exclusive speciﬁcity on these lectins. This study analyzed the participa-
tion of some amino acids in the speciﬁcity of tarin. The effects of chem-
icalmodiﬁcation of residueswithin the conservedmotif on tarin activity
are summarized in Table 2. Modiﬁcation of arginine (R), lysine (K) and
serine (S) had no effect on the hemagglutinating activity of tarin, indi-
cating that these residues do not participate in the binding activity. Sim-
ilarly, no change in tarin activity was observed after DTNB treatment,
suggesting that the sulfhydryl groups are not involved in lectin activity.
Modiﬁcation of tryptophan (W) or aspartic/glutamic residues (D/E)
resulted in partial losses of activity, indicating that these residues are
probably involved in the binding activity.
Comparison of the four non-identical amino acid sequences of tarin
found in the data bank resulted in the detection of two functional carbo-
hydrate recognition sites (CRS) [36]. The presence of two aspartic resi-
dues in the ﬁrst binding site (QD/NDCNLVLY) and one in the second
(QGNDCNLVLY), in addition to the presence of the same amino acid in
the vicinity, could explain the loss in activity when aspartic residues
were modiﬁed.
Although no tryptophan residue is found in the consensus sequence
of the binding site, some of this residue is located around it (W63/67,
W95/99, W29, W84, W216). One of the tryptophan residues is very
close to the CRS, suggesting that the residue is involved or participates
in maintaining the conformation of the binding pocket.
Modiﬁcation of tyrosine (Y) residues resulted in 75% loss of activity,
suggesting that these residues participate in the binding activity. Tyro-
sine is one of the amino acids present in the conserved consensusTable 2
Chemical modiﬁcation of tarin residues.
Residue modiﬁed Reagent used Hemagglutinating activity (%)
Serine PMSF 100
Lysine NaBH4 100
Tryptophan HNB 75
Tyrosine N-acetylimidazole 25
Sulfhydryl groups DTNB 100
Cysteine Iodoacetamide 100
Arginine HPG 100
Aspartic/glutamic acid EDC 75
PMSF Phenylmethylsulfonylﬂuoride
NaBH4 Sodium borohydride
HNB 2-Hydroxy-5-nitrobenzylbromide
DTNB 5-5′-Dithio-bis (2-nitrobenzoic acid) or Ellman's reagent
HPG p-Hydroxyphenylglyoxal
EDC 1-Ethyl-3-(3-dimethylaminopropyl) carboxiimide
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the functionality of the binding site.
3.6. Speciﬁcity of tarin–carbohydrate binding
The sugar speciﬁcity of tarinwas evaluated by hapten inhibition of the
hemagglutinating activity. The hemagglutinating activity of the lectinwas
inhibited by four glycoproteins (asialofetuin, asialoagalactofetuin, bovine
submaxillary mucin and bovine thyroglobulin) of the 18 haptens tested
(Table 3). The simple sugars or oligosaccharides, including mannose,
and its oligomers did not show inhibitory activity, indicating that tarin
has complex sugar speciﬁcity.
Glycan microarray analysis was performed through the Functional
Glycomics Gateway (http://www.functionalglycomics.org/), using
tarin at 0.2, 2.0, 20.0 and 200.0 μg/mL concentrations. The 30 highest av-
erage rank values, which rank the glycans bound to tarin according to
their relative strength of binding in terms of total ﬂuorescence, were
calculated as described previously [37], excluding the ﬂuorescence
data from 200.0 μg/mL of tarin, to avoid evaluation of non-speciﬁc inter-
actions (Table 4). The ﬂuorescence signal increased roughly threefold
for most glycans when the concentration of tarin was increased from
2.0 to 20.0 μg/mL. The data obtained at 20.0 μg/mL tarin are presented
in Figs. 3 and 4. The glycan microarray results conﬁrmed the complex
sugar speciﬁcity exhibited by tarin in the hapten inhibition assays. The
puriﬁed protein showed strong afﬁnity toward the biantennary com-
plex glycans, paucimannose and oligomannose glycans, and their
fucosylated counterparts (Table 4).
The shortest tarin ligand in the microarray was the core pentasaccha-
rideManα1-3(Manα1-6)Manβ1-4GlcNAcβ1-4GlcNAcβ (Table 4, glycans
49 and 50). The addition of two or three extramannose residues toα-1,3/
α-1,6 linked mannose in the pentasaccharide core increased the binding
strength, as seen in glycans 213 and 212 (Fig. 3). Further extension
of the triantennary complex with extra mannose residues weakenedTable 3
Hemagglutination-inhibition test.
Haptens tested Minimum concentration required
for inhibition (MIC) μg/mL
1 — Fetuin 1.3 mg/mL NI
2 — Asialofetuin 1 mg/mL 31.3
3 — Asialogalactofetuin 1 mg/mL 62.5
4 — Bov. Sub. Mucin 1 mg/mL 125.0
5 — Asialomucin 1 mg/mL NI
6 — Bov. Thyroglobulin 2 mg/mL 250.0
7 — Yeast Mannan 2 mg/mL NI
8 —Mannose 100 mM NI
9 —Me-α-man 100 mM NI
10 —M-α-2M 50 mM NI
11 — Glc 200 mM NI
12 — Glc NAc 100 mM NI
13 —M3 NI
14 —M5 NI
15 —Me-α-Gal 100 mM NI
16 — LacNAc 100 mM NI
17 — GalNAc 100 mM NI
18 — L-Fucose 200 mM NI
NI No inhibition
Bov. Sub. Mucin bovine submaxillary mucin
Me-α-man Methyl-α-D-Mannopyranoside
M-α-2M Mannose-α-2-mannose
Glc Glucose
GlcNAc N-Acetyl-D-Glucosamine
Me-α-Gal Methyl-α-D-Galactopyranoside
LacNAc N-Acetyl-D-Lactosamine
GalNAc N-Acetyl-D-Galactosamine
M3 Trimannoside
M5 Pentamannoside
Agglutination inhibition was evaluated using 2% rabbit cells treated with trypsin.(glycan 208) or abolished (glycans 209 and 207) the tarin–carbohydrate
interaction (Fig. 3). The chitobiose core and the asparagine present in the
glycan stalk (glycan 49) likely contribute to the binding and speciﬁcity of
tarin, since the protein did not bind to trimannose (Manα1-3(Manα1-6)
Manα-Sp9, glycan 210). Additionally, the fucosylation at position 6 of the
ﬁrst N-acetyl glucosamine (Fig. 3, glycan 477) increased the binding
strength. Interestingly, the replacement of asparagine linked to the
pentasaccharide core (glycan 49) by glycine (glycan 50), which could re-
lieve the steric hindrance at the binding site or allow additional interac-
tions between the closest α-carboxyl group of glycine with the binding
site, also increased the binding strength.
Glycans 212 and 213 (Table 4) can also be found as part of the gp120
glycoprotein of HIV-1 [38] and of the CA-125 glycoprotein antigen of
epithelial ovarian cancer cells [39], respectively. Glycan 477 is found
in insect glycoproteins [40]. Paucimannose (glycan 49) is commonly
found in insects and nematodes [41] and in cancerous, but not in
healthy tissues from humans [42].
Fig. 4 lists some selected complex glycans that showed high
binding afﬁnity. Glycans were covalently bonded to free asparagine
and asparaginyl residuewithin a peptide. Most of them are biantennary
glycans that have in common two identical antennae linked toManα1-
6 and Manα1-3 in the pentasaccharide core. These structures can be
elongated by successive addition of GlcNAc (β1,2-linked to mannose)
and/or Gal (β1,4 or β1,3-linked to GlcNAc) that can be capped with
fucose, galactose or Neu5Ac. Structures with an additional fucose
(α1,3-linked) to GlcNAc in the antenna or in the chitobiose core (α-
1,6-linked) also showed afﬁnity to tarin. However, given the complex
nature of these glycans, the lack of intermediate structures in themicro-
array, and the difference in peptide sequences bound to glycans, there is
insufﬁcient information to establish the individual contribution of sugar
alterations that could increase the binding strength and speciﬁcity of
glycans to tarin.
Triantennary glycan 366- and tetra-antennary glycan 384-containing
antennae, which are formed by the disaccharide Galβ-1,4GlcNAc (β1,2
or β1,4-linked to mannose), were also good ligands for tarin. Indeed,
the binding of tetra-antennary glycan 384 (RFU 34,583 ± 1523) was
similar to that of glycan 465 (33,668 ± 391), the best biantennary
ligand for tarin at the concentration of 20 μg/mL.
It has been reported that the introduction of bisecting GlcNAc
and/or core fucosylation can reduce the number of major glycan
conformers, since they shift the conformational equilibrium and in-
crease binding stringency, favoring a conformer-speciﬁc glycan recep-
tor [43]. Fucosylation of the chitobiose stalk as seen in glycans 465,
475, 476 and in 350,was not able to determine the role of the chitobiose
stalk fucosylation in glycan binding. Fucosylation increased the binding
of tarin to glycan 475 threefold, in comparison to its unfucosylated form
(glycan 323) (Fig. 4). On the other hand, fucosylated glycan 350 showed
weaker binding than glycan 53, although they have similar structures.
Because glycans 53 and 350 also differ in the amino acid extension of
the chitobiose core (asparagine in glycan 53 and the tripeptide NST in
glycan 350), it cannot be determined if the inhibitory effect was due
to the fucosylation or to the NST peptide.
Interestingly, the terminal sequence in the antenna of glycan 465 is
equal to Lewisy-type tetrasaccharide (Fucα1-2Galβ1-4(Fuca α1-3)
GlcNAc) which is found in N-linked, O-linked or lipid-linked terminal
glycan structures [44]. The Lewisy epitope is a relatively rare sequence
in humans. It is found in small amounts in normal epithelial cells,
including those in the stomach and colon [45], and is also found in N-
glycans of human seminal plasma [46], human sperm [47], hematopoi-
etic progenitor cells [48], and in peripheral blood granulocytes [49]. Ley
expression is increased inmost epithelial-derived cancer cells, including
colon, stomach, ovary, breast, pancreas, prostate and lung, and is gener-
ally considered to be a cancer-associated antigen [50]. Also, glycan 358
characterizes the antigen H2 (CD173-Fucα1-2Galβ1-4GlcNAcβ1-),
which can be found in leukemic cells and in hematopoietic progenitor
cells [48]. These ﬁndings explain the proliferative properties, reported
Table 4
Tarin speciﬁcity by glycan microarray.
Glycan Glycan structure Mean rank
High-mannose N-glycans
212 Manα1-6(Manα1-3)Manα1-6(Manα1-2Manα1-3)Manβ1-4GlcNAcβ1-4GlcNAcβ-Sp12 37.7
477 Manα1-6(Manα1-3)Manβ1-4GlcNAcβ1-4(Fucα1-6)GlcNAcβ-Sp19 30.9
213 Manα1-6(Manα1-3)Manα1-6(Manα1-3)Manβ1-4GlcNAcβ1-4GlcNAcβ-Sp12 27.3
50 Manα1-3(Manα1-6)Manβ1-4GlcNAcβ1-4GlcNAcβ-Sp13 17.4
49 Manα1-3(Manα1-6)Manβ1-4GlcNAcβ1-4GlcNAcβ-Sp12 8.1
Complex N-glycans
465 Fucα1-2Galβ1-4(Fucα1-3)GlcNAcβ1-2Manα1-6(Fucα1-2Galβ1-4(Fucα1-3)GlcNAcβ1-2Manα1-3)Manβ1-4GlcNAcβ1-4(Fucα1-6)GlcNAcβ-6AA 97.9
475 Neu5Acα2-6Galβ1-4GlcNAcβ1-2Manα1-6(Neu5Acα2-6Galβ1-4GlcNAcβ1-2Manα1-3)Manβ1-4GlcNAcβ1-4(Fucα1-6)GlcNAcβ-6AA 83.8
384 Galβ1-4GlcNΑcβ1-2(Galβ1-4GlcNΑcβ1-4)Manα1-3(Galβ1-4GlcNΑcβ1-2(Galβ1-4GlcNΑcβ1-6)Manα1-6)Manβ1-4GlcNΑcβ1-4GlcNΑcβ-Sp21 75.3
321 Galβ1-3GlcNAcβ1-2Manα1-3(Galβ1-3GlcNAcβ1-2Manα1-6)Manβ1-4GlcNAcβ1-4GlcNAcβ-Sp19 38.8
476 Neu5Acα2-3Galβ1-4GlcNAcβ1-2Manα1-6(Neu5Acα2-3Galβ1-4GlcNAcβ1-2Manα1-3)Manβ1-4GlcNAcβ1-4(Fucα1-6)GlcNAcβ-6AA 38.4
385 GlcNΑcβ1-2(GlcNΑcβ1-4)Manα1-3(GlcNΑcβ1-2Manα1-6)Manβ1-4GlcNΑcβ1-4GlcNΑc-Sp21 37.8
366 Galβ1-4GlcNAcβ1-2(Galβ1-4GlcNAcβ1-4)Manα1-3(Galβ1-4GlcNAcβ1-2Manα1-6)Manβ1-4GlcNAcβ1-4GlcNAc-Sp21 36.7
400 Galα1-4Galβ1-4GlcNΑcβ1-2Manα1-3(Galα1-4Galβ1-4GlcNΑcβ1-2Manα1-6)Manβ1-4GlcNΑcβ1-4GlcNΑcβ-LVΑNKT 33.9
399 Galα1-4Galβ1-3GlcNΑcβ1-2Manα1-3(Galα1-4Galβ1-3GlcNΑcβ1-2Manα1-6)Manβ1-4GlcNΑcβ1-4GlcNΑcβ-Sp19 30.6
350 Galβ1-4GlcNAcβ1-2Manα1-3(Galβ1-4GlcNAcβ1-2Manα1-6)Manβ1-4GlcNAcβ1-4(Fucα1-6)GlcNAcβ-Sp22 20.6
351 Galβ1-3GlcNAcβ1-2Manα1-3(Galβ1-3GlcNAcβ1-2Manα1-6)Manβ1-4GlcNAcβ1-4(Fucα1-6)GlcNAcβ-Sp22 18.4
466 Fucα1-2Galβ1-3(Fucα1-4)GlcNAcβ1-2Manα1-6(Fucα1-2Galβ1-3(Fucα1-4)GlcNAcβ1-2Manα1-3)Manβ1-4GlcNAcβ1-4(Fucα1-6)GlcNAcβ-Sp19 17.9
52 GlcNAcβ1-2Manα1-3(GlcNAcβ1-2Manα1-6)Manβ1-4GlcNAcβ1-4GlcNAcβ-Sp13 16.8
360 Galα1-3Galβ1-4GlcNAcβ1-2Manα1-3(Galα1-3Galβ1-4GlcNAcβ1-2Manα1-6)Manβ1-4GlcNAcβ1-4GlcNAcβ-Sp20 16.3
348 Galβ1-4GlcNAcβ1-2Manα1-3(Manα1-6)Manβ1-4GlcNAcβ1-4GlcNAcβ-Sp12 14.2
53 Galβ1-4GlcNAcβ1-2Manα1-3(Galβ1-4GlcNAcβ1-2Manα1-6)Manβ1-4GlcNAcβ1-4GlcNAcβ-Sp12 13.8
393 Galβ1-4GlcNAcβ1-2Manα1-3(GlcNAcβ1-2Manα1-6)Manβ1-4GlcNAcβ1-4GlcNAc-Sp12 12.5
424 Galα1-3(Fucα1-2)Galβ1-4GlcNAcβ1-2Manα1-3(Galα1-3(Fucα1-2)Galβ1-4GlcNAcβ1-2Manα1-6)Manβ1-4GlcNAcβ1-4(Fucα1-6)GlcNAcβ-Sp22 12.4
323 Neu5Acα2-6Galβ1-4GlcNAcβ1-2Manα1-3(Neu5Acα2-3Galβ1-4GlcNAcβ1-2Manα1-6)Manβ1-4GlcNAcβ1-4GlcNAcβ-Sp12 10.5
358 Fucα1-2Galβ1-4GlcNAcβ1-2Manα1-3(Fucα1-2Galβ1-4GlcNAcβ1-2Manα1-6)Manβ1-4GlcNAcβ1-4GlcNAcβ-Sp20 10.0
349 GlcNAcβ1-2Manα1-3(GlcNAcβ1-2Manα1-6)Manβ1-4GlcNAcβ1-4(Fucα1-6)GlcNAcβ-Sp22 9.9
54 Neu5Acα2-6Galβ1-4GlcNAcβ1-2Manα1-3(Neu5Acα2-6Galβ1-4GlcNAcβ1-2Manα1-6)Manβ1-4GlcNAcβ1-4GlcNAcβ-N(LT)AVL 9.9
368 Galα1-3(Fucα1-2)Galβ1-4GlcNAcβ1-2Manα1-3(Galα1-3(Fucα1-2)Galβ1-4GlcNAcβ1-2Manα1-6)Manβ1-4GlcNAcβ1-4GlcNAcβ-Sp20 9.9
371 Galα1-3(Fucα1-2)Galβ1-3GlcNAcβ1-2Manα1-3(Galα1-3(Fucα1-2)Galβ1-3GlcNAcβ1-2Manα1-6)Manβ1-4GlcNAcβ1-4GlcNAcβ-Sp20 9.0
361 Manα1-3(Galβ1-4GlcNAcβ1-2Manα1-6)Manβ1-4GlcNAcβ1-4GlcNAcβ-Sp12 7.5
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stimulate the in vitro and in vivo proliferation of mouse hematopoietic
cells, particularly the B cell population [12].Fig. 3.High-mannose N-linked glycan-bound tarin in a glycanmicroarray. Structures of high-ma
in Table VII. Green square — N-acetylglucosamine; red circle — mannose; orange triangle —
20 μg/mL tarin. Some glycan structures that do not bind to tarin are presented for comparisonBiantennary glycan 475/A2F and glycan 323/A2 (unfucosylated),
two N-linked glycans that are commonly found in mammals, showed
the terminal carbohydrate sequence Neu5Aca2–6Galβ1–4GlcNAc βnnose oligosaccharide-bound tarin in the glycanmicroarray. Glycan number is the same as
fucose. RFU (relative ﬂuorescence unit) was obtained from a glycan microarray assay at
. Asn* (glycan 477) is asparagine in dipeptide EN or NK.
Fig. 4. Structures of complex glycan-bound tarin in the glycanmicroarray. Glycan number is the same as in Table VII and in the supplementary data. Green square—N-acetylglucosamine;
red circle—mannose; orange triangle— fucose; white circle— galactose;white square—N-acetylneuraminic acid. RFU (relativeﬂuorescence unit) was obtained from a glycanmicroarray
assay at 20 μg/mL tarin. Some glycan structures that do not bind to tarin are presented for comparison.
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binds with high afﬁnity to all human inﬂuenza A and B viruses [51],
and glycan 323 can protect mice from experimental inﬂuenza infection
[52]. Glycan 323was able to bind to Colchicum autumnale agglutinin and
Tulipa hybrid lectin in a glycan microarray assay [53].
The above results for tarin sugar-binding speciﬁcity are in agree-
ment with those reported by Van Damme and colleagues [53], who
showed that the majority of two-domain monocot-mannose binding
lectins are able to strongly interact with both high-mannose and com-
plex N-glycans. The presence of multiple isolectins in our preparation
may account for the complex speciﬁcity shown by tarin and shared by
other lectins of this family, as mentioned previously [30].
However, Van Damme and colleagues [53] reported the occurrence
of multiple independent domain duplication/tandem events among
most of the known two-domain GNA-related lectins. The sequence of
the amino acids that compose the binding sites of two-domain lectins
is less conservative than in the single-domain lectins. As a result, two-
domain lectins exhibit dual speciﬁcity toward different targets, includ-
ing both high-mannose and complex N-glycans, typical animal glycans,
which supports the idea that these proteins evolved for purposes of
defense.
The four primary sequences of tarin deposited in the data bank con-
tain two functional binding sites. The second binding site differs from
the ﬁrst in one amino acid substitution (D52/G171). However, the
four entries share the same sequence in the second binding site [36].
Except for one of the sequences (A5HMM7_COLES) where the aspartic
residue is replaced by asparagine in the ﬁrst binding site, all the otheramino acids are identical. Although the composition of their binding
sites is strongly conserved, they all have different pIs as revealed by
ProtParam analysis, which suggests that each entry represents a
speciﬁc tarin isoform. The complex speciﬁcity exhibited by tarin glycan
binding is not an exclusive behavior of this protein, but rather is a com-
mon characteristic shared by most of the two-domain lectins of this
family. Therefore, it is more likely that the complex speciﬁcity results
from a process of divergence than from a heterogeneous mixture of
isolectins.
Our results for tarin binding speciﬁcity provide a molecular basis for
tarin's insecticidal activity [18,54] and its anti-metastatic activity
against breast and prostate-cancer cell lines [55], and point to possible
new applications for this biotechnologically versatile protein.
4. Conclusions
Treatment of a tarin preparation in different pHs and temperatures
showed that it is a stable glycoprotein whose activity does not depend
on metal ions, and is probably encoded by a multigene family, as evi-
denced by the 2-DE results. The results of the mass spectrometry (ESI
and MALDI) indicate that the tarin monomers are held together by
non-covalent bonds to form its biological unit, a tetramer of 47 kDa.
Binding studies of tarin conﬁrmed its preference for complex and
high-mannose glycans including speciﬁc antigens, which concords
with its remarkable antitumor, antiviral and insecticidal properties.
This detailed study of puriﬁed tarin indicates that it is a stable protein
that can be exploited for a variety of purposes.
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PMSF Phenylmethylsulfonylﬂuoride
NaBH4 Sodium Borohydride
HNB 2-Hydroxy-5-Nitrobenzylbromide
DTNB 5-5′-Dithio-bis (2-nitrobenzoic acid) or Ellman's reagent
HPG p-Hydroxyphenylglyoxal;
EDC 1-Ethyl-3-(3-dimethylaminopropyl) carboxiimide
Me-α-man Methyl-α-DMannopyranoside;
M-α-2M Mannose-α-2-mannose
Glc Glucose
GlcNAc N-Acetyl-D-glucosamine
Me-α-Gal Methyl-α-DGalactopyranoside
LacNAc N-Acetyl-D-Lactosamine
GalNAc NAcetyl-D-Galactosamine
M3 Trimannoside
M5 Pentamannoside
2-DE Two-dimensional electrophoresis
SDS-PAGE Sodium dodecyl sulfate polyacrylamide gel electrophoresis
PBS Phosphate-buffered saline
ESI-MS Electrospray ionization mass spectrometry
MALDI-TOF Matrix-assisted laser desorption/ionization time of ﬂight
LC-MS Liquid chromatography mass spectrometry
MALS Multi-angle light scattering
IPG Immobilized pH gradient
IEF Isoelectric focusing
GNA-lectin Galanthus nivalis lectin
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